These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21917849)

  • 1. Brain amyloid imaging.
    Rowe CC; Villemagne VL
    J Nucl Med; 2011 Nov; 52(11):1733-40. PubMed ID: 21917849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain amyloid imaging.
    Rowe CC; Villemagne VL
    J Nucl Med Technol; 2013 Mar; 41(1):11-8. PubMed ID: 23396994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
    Wolk DA; Sadowsky C; Safirstein B; Rinne JO; Duara R; Perry R; Agronin M; Gamez J; Shi J; Ivanoiu A; Minthon L; Walker Z; Hasselbalch S; Holmes C; Sabbagh M; Albert M; Fleisher A; Loughlin P; Triau E; Frey K; Høgh P; Bozoki A; Bullock R; Salmon E; Farrar G; Buckley CJ; Zanette M; Sherwin PF; Cherubini A; Inglis F
    JAMA Neurol; 2018 Sep; 75(9):1114-1123. PubMed ID: 29799984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.
    Leuzy A; Zimmer ER; Heurling K; Rosa-Neto P; Gauthier S
    Amyloid; 2014 Sep; 21(3):143-8. PubMed ID: 24919109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.
    Chiotis K; Carter SF; Farid K; Savitcheva I; Nordberg A;
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1492-506. PubMed ID: 26130168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images.
    Buckley CJ; Sherwin PF; Smith AP; Wolber J; Weick SM; Brooks DJ
    Nucl Med Commun; 2017 Mar; 38(3):234-241. PubMed ID: 27984539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S
    Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Higashi T; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
    Ann Nucl Med; 2018 Apr; 32(3):206-216. PubMed ID: 29388083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir.
    Trembath L; Newell M; Devous MD
    J Nucl Med Technol; 2015 Sep; 43(3):175-84. PubMed ID: 26271806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
    Johnson KA; Minoshima S; Bohnen NI; Donohoe KJ; Foster NL; Herscovitch P; Karlawish JH; Rowe CC; Carrillo MC; Hartley DM; Hedrick S; Pappas V; Thies WH
    J Nucl Med; 2013 Mar; 54(3):476-90. PubMed ID: 23359661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.
    van Berckel BN; Ossenkoppele R; Tolboom N; Yaqub M; Foster-Dingley JC; Windhorst AD; Scheltens P; Lammertsma AA; Boellaard R
    J Nucl Med; 2013 Sep; 54(9):1570-6. PubMed ID: 23940304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
    Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
    J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.
    Kadir A; Almkvist O; Forsberg A; Wall A; Engler H; Långström B; Nordberg A
    Neurobiol Aging; 2012 Jan; 33(1):198.e1-14. PubMed ID: 20688420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO; Wong DF; Wolk DA; Leinonen V; Arnold SE; Buckley C; Smith A; McLain R; Sherwin PF; Farrar G; Kailajärvi M; Grachev ID
    Acta Neuropathol; 2012 Dec; 124(6):833-45. PubMed ID: 23053137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular imaging of beta-amyloid plaques in the brain].
    Ono M
    Brain Nerve; 2007 Mar; 59(3):233-40. PubMed ID: 17370649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?
    Dubroff JG; Nasrallah IM
    Acad Radiol; 2015 Aug; 22(8):988-94. PubMed ID: 26100192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging.
    Hommet C; Mondon K; Camus V; Ribeiro MJ; Beaufils E; Arlicot N; Corcia P; Paccalin M; Minier F; Gosselin T; Page G; Guilloteau D; Chalon S
    Dement Geriatr Cogn Disord; 2014; 37(1-2):1-18. PubMed ID: 24107621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.